Amadeo Parissenti

5PUBLICATIONS
6CO-AUTHORS
Proteomics and intermolecular interactions (excl. medical proteomics)Haematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 19, 2023
Low RNA disruption during neoadjuvant chemotherapy predicts pathologic complete response absence in patients with breast cancer.

Marina Elena Cazzaniga, Foluso Ademuyiwa, Thierry Petit

|Dec 18, 2019
RNA disruption indicates CHOP therapy efficacy in canine lymphoma.

Amadeo M Parissenti, Laura B Pritzker, Baoqing Guo

Pageof 1